Skip to content

Chinese medicine prospective cohort study of non-small cell lung cancer based on real world

Chinese medicine prospective cohort study of non-small cell lung cancer based on real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079067
Enrollment
Unknown
Registered
2023-12-25
Start date
2023-12-31
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Exposed group (TCM (traditional Chinese medicine) therapy):NA
Non-exposed group (Conventional western medicine treatment):NA

Sponsors

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Pathological or cytological diagnosis of lung cancer (newly diagnosed or previously diagnosed); (2) Age =18 years old, gender unlimited; (3) Voluntarily join the clinical trial and sign the informed consent;(4) Receive anti-tumor or surgical treatment.

Exclusion criteria

Exclusion criteria: (1) patients with mental illness and lack of autonomous ability; (2) subjects that the investigator considers unable to cooperate with the completion of the clinical investigation; (3) According to the judgment of the researcher, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the working environment and unstable living environment, which are easy to cause the loss of follow-up; (4) Combined with active pulmonary tuberculosis, bronchial asthma, bronchiectasis, pulmonary abscess, pneumoconiosis and other respiratory diseases; (5) Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Overall survival;Recurrence rate;

Secondary

MeasureTime frame
Progression free survival;Solid tumor change;Tumor marker;European Cancer Research and Treatment Tissue Quality of Life Scale;Karnofsky Function status score;

Countries

China

Contacts

Public ContactLi Suyun

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

lisuyun2000@126.com+86 139 3841 5502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026